Often compared to as the Bloomberg Terminal for life sciences R&D, Catalytic is innovating on the cutting edge of software and therapeutics to fuel scientific research and collaboration; bringing together real-time research data, news, unrivaled library management, powerful analytics, data management, communication tools and world-class research capabilities — in one groundbreaking, fully integrated and highly secure R&D cloud platform.
In the following article, Scott Sacane, Founder and CEO of Catalytic Data Science, sits down with KM World to discuss how Catalytic is working to put sophisticated technology in the hands of researchers to help improve translational success rates in early stage therapeutic development.
